Biologics

Beazley expands healthcare and life sciences capability in Asia

Specialist insurer Beazley has appointed Prashansa Daga as Miscellaneous Medical & Life Sciences underwriter to support the expansion of its Healthcare...

 July 12, 2021 | News

Molecules in motion

St. Jude Children's Research Hospital scientists have used smFRET and cyro-EM to capture structures of a biologic process through research that has imp...

 July 12, 2021 | News

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two compa...

 July 09, 2021 | News

Univercells Tech and VectorBuilder announce partnership for optimized custom viral vector production

Agreement to encompass co-development and optimization of protocols for intensified and continuous viral vector production for cell and gene therapies and ...

 July 07, 2021 | News

Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara

Alvotech, today, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT...

 July 06, 2021 | News

Sartorius provides preliminary first-half financial key figures

Sartorius announces today that it expects strong first–half performance and raises its forecast for the full year of 2021. For the first six months e...

 July 06, 2021 | News

Sartorius strengthens product portfolio by acquiring CellGenix

The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. ...

 July 02, 2021 | News

Evonik markets new advanced technology for sustainable pharmaceutical production

Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...

 June 30, 2021 | News

Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme

Yposkesi, a best-in-class Contract Development and Manufacturing Organization (CDMO) for companies developing cell and gene therapies, today announces the ...

 June 29, 2021 | News

Innovent Announces An Agreement with Synaffix

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

 June 29, 2021 | News

Waters to Help Accelerate Biologics Production Through Research Collaboration With SBTI

Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research...

 June 28, 2021 | News

Nucleai and Merck Launch Translational Medicine Collaboration

Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development...

 June 25, 2021 | News

Duke-NUS and GenScript notice of allowance for U.S. patent application for SARS-CoV-2 surrogate virus neutralisation test

Developed by Professor Linfa Wang and his team from Duke-NUS, the sVNT neutralization antibody detection technology is exclusively licensed to Ge...

 June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

 June 24, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close